NCT00597623View on ClinicalTrials.gov

Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

December 31, 2010

Conditions
Hand Osteoarthritis
Interventions
OTHER

Adalimumab (Humira®)

syringes for injections under cutaneous dose = 40mg vol = 0.8 ml

OTHER

Placebo

syringes under cutaneous vol = 8 ml

Trial Locations (1)

94000

CHU Henri Mondor, Créteil

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00597623 - Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis | Biotech Hunter | Biotech Hunter